Two sample MR report
Arachidonoylcarnitine (C20:4) levels against Rheumatoid arthritis || id:ebi-a-GCST90018910
Date: 08 November, 2026
Results from two sample MR:
| method |
nsnp |
b |
se |
pval |
| MR Egger |
9 |
-0.0230390 |
0.0517196 |
0.6694378 |
| Weighted median |
9 |
0.0281261 |
0.0313241 |
0.3692363 |
| Inverse variance weighted |
9 |
0.0532224 |
0.0249327 |
0.0327903 |
| Simple mode |
9 |
0.0323797 |
0.0420096 |
0.4629973 |
| Weighted mode |
9 |
0.0338719 |
0.0303224 |
0.2963926 |
Heterogeneity tests
| method |
Q |
Q_df |
Q_pval |
| MR Egger |
5.462343 |
7 |
0.6037298 |
| Inverse variance weighted |
8.267336 |
8 |
0.4078013 |
Test for directional horizontal pleiotropy
| egger_intercept |
se |
pval |
| 0.0190304 |
0.0113627 |
0.1378814 |
Test that the exposure is upstream of the outcome
| snp_r2.exposure |
snp_r2.outcome |
correct_causal_direction |
steiger_pval |
| 0.0101625 |
0 |
TRUE |
0 |
Note - R^2 values are approximate
Forest plot of single SNP MR

Comparison of results using different MR methods

Funnel plot

Leave-one-out sensitivity analysis
